These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. What is potent acid inhibition, and how can it be achieved? Calvet X; Gomollón F Drugs; 2005; 65 Suppl 1():13-23. PubMed ID: 16335854 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician. Huang JQ; Hunt RH Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of gastric acid secretion and therapeutic results: is there any correlation? Corinaldesi R; Ghidini C; Ricci Maccarini M; Santaguida P; Fratesi E; Barbara G; Stanghellini V Ital J Gastroenterol; 1990; 22 Suppl 1():2-4. PubMed ID: 1983421 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic drug interaction profiles of proton pump inhibitors. Blume H; Donath F; Warnke A; Schug BS Drug Saf; 2006; 29(9):769-84. PubMed ID: 16944963 [TBL] [Abstract][Full Text] [Related]
12. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase. McArthur KE; Jensen RT; Gardner JD Annu Rev Med; 1986; 37():97-105. PubMed ID: 3010811 [TBL] [Abstract][Full Text] [Related]
13. Considerations for long-term use of proton-pump inhibitors. Garnett WR Am J Health Syst Pharm; 1998 Nov; 55(21):2268-79. PubMed ID: 9825878 [TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor side effects and drug interactions: much ado about nothing? Madanick RD Cleve Clin J Med; 2011 Jan; 78(1):39-49. PubMed ID: 21199906 [TBL] [Abstract][Full Text] [Related]
15. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations. Devault KR Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410 [TBL] [Abstract][Full Text] [Related]
16. Is there a dark side to long-term proton pump inhibitor therapy? Nealis TB; Howden CW Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138 [TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors and acid-related diseases. Sachs G Pharmacotherapy; 1997; 17(1):22-37. PubMed ID: 9017763 [TBL] [Abstract][Full Text] [Related]
18. Risks versus benefits of long-term proton pump inhibitor therapy in the elderly. Schuler A Geriatr Nurs; 2007; 28(4):225-9. PubMed ID: 17936957 [No Abstract] [Full Text] [Related]
19. Safety, pharmacokinetics, and pharmacodynamics of S-(-)-pantoprazole sodium injections after single and multiple intravenous doses in healthy Chinese subjects. Jiao HW; Sun LN; Li YQ; Yu L; Zhang HW; Wang MF; Yu LY; Yuan ZQ; Xie LJ; Chen J; Meng L; Zhang XH; Wang YQ Eur J Clin Pharmacol; 2018 Mar; 74(3):257-265. PubMed ID: 29167917 [TBL] [Abstract][Full Text] [Related]
20. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas. Jensen RT Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]